Skip to content

Viking Therapeutics

US · VKTX #2352 by market cap Listed 2015
28.54 +0.16 +0.56%
Live - 5344 symbols - heartbeat 552s ago · 2026-10-08 07:39
Pre-market 28.60 +0.23%
After-hours 28.62 +0.29%
Overnight 28.41 -0.46%
Market cap
3.59B
P/B
8.78
EPS
-3.19
Reader sentiment Are you bullish or bearish on VKTX?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $87 to $125
    Market Newswire · 2026/9/23
  • Rating change
    Jefferies Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $101
    Market Newswire · 2026/7/30
  • Rating change
    A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $71 to $114
    Market Newswire · 2026/7/30
  • J.P. Morgan Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Cuts Target Price to $65
    Market Newswire · 2026/8/11
  • Rating change
    H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102
    Market Newswire · 2026/6/24
  • Rating change
    Maxim Group Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $70
    Market Newswire · 2026/8/1
  • Rating change
    Raymond James Maintains Viking Therapeutics(VKTX.US) With Buy Rating
    Market Newswire · 2026/6/24
  • Rating change
    B. Riley Securities Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $85
    Market Newswire · 2026/6/25
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) and Aytu BioScience (AYTU)
    TipRanks · 2026/9/23
  • Rating change
    Morgan Stanley Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $95
    Market Newswire · 2026/7/30
  • Cantor Fitzgerald Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100
    Market Newswire · 2026/8/14
  • Rating change
    Stifel Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $95
    Market Newswire · 2026/7/30
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Viking Therapeutics (VKTX)
    TipRanks · 2026/6/25
  • Rating change
    Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100
    Market Newswire · 2026/8/3
  • Rating change
    CCORF Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $107
    Market Newswire · 2026/7/15
  • Rating change
    Analysts Are Bullish on Top Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX)
    TipRanks · 2026/9/23
  • A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $70 to $114
    Market Newswire · 2026/9/24
  • Rating change
    Piper Sandler Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $71
    Market Newswire · 2026/7/7
  • B. Riley Securities Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $85
    Market Newswire · 2026/9/9

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:39:31 · For reference only, not investment advice and not tailored to your situation.